Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Dec 31;16(1):198.
doi: 10.3390/cancers16010198.

Comparing Methods to Determine Complete Response to Chemoradiation in Patients with Locally Advanced Cervical Cancer

Kim van Kol  1   2 , Renée Ebisch  3 , Maaike Beugeling  4 , Jeltsje Cnossen  5 , Joost Nederend  6 , Dennis van Hamont  7 , Sjors Coppus  8 , Jurgen Piek  1 , Ruud Bekkers  1   2   3
Affiliations

Comparing Methods to Determine Complete Response to Chemoradiation in Patients with Locally Advanced Cervical Cancer

Kim van Kol et al. Cancers (Basel). .

Abstract

Objectives: There is no consensus on the most reliable procedure to determine remission of cervical cancer after chemoradiotherapy (CRT). Therefore, this study aims to assess the diagnostic performance of two different imaging techniques, MRI and 18F[FDG]-PET/CT, in determining the presence of locoregional residual disease after CRT in patients with locally advanced cervical cancer.

Methods: Patients diagnosed with locally advanced cervical cancer (FIGO 2009) treated with CRT were retrospectively identified from a regional cohort. The accuracy of MRI and 18F[FDG]-PET/CT in detecting locoregional residual disease was assessed with histology as the reference standard.

Results: The negative predictive value (NPV) and positive predictive value (PPV) for locoregional residual disease detection of MRI and 18F[FDG]-PET/CT combined were 84.2% (95% CI 73.2-92.1), and 70.4% (95% CI 51.8-85.2), respectively. The NPV and PPV of MRI alone were 80.2% (95% CI 71.2-87.5) and 47.7% (95% CI 35.8-59.7), respectively, and values of 81.1% (95% CI 72.2-88.3) and 55.8 (95% CI 42.2-68.7), respectively, were obtained for 18F[FDG]-PET/CT alone.

Conclusion: In this study, the reliability of MRI and 18F[FDG]-PET/CT in detecting locoregional residual disease was limited. Combining MRI and 18F[FDG]-PET/CT did not improve predictive values. Routine use of both MRI and 18F[FDG]-PET/CT in the follow-up after CRT should be avoided. MRI during follow-up is the advised imaging technique. Pathology confirmation of the presence of locoregional residual disease before performing salvage surgery is warranted.

Keywords: 18F[FDG]-PET/CT; MRI; chemoradiotherapy; locally advanced cervical cancer; radiologic imaging; residual disease; salvage surgery; survival.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no conflicts of interest.

Figures

Figure 1
Figure 1
Patient selection flow chart. ROGY: Registration system Oncological Gynecology. LACC: locally advanced cervical cancer. CRT: chemoradiation therapy.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F., Bsc M.F.B., Me J.F., Soerjomataram M.I., et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA A Cancer J. Clin. 2021;71:209–249. doi: 10.3322/caac.21660. - DOI - PubMed
    1. Bhatla N., Aoki D., Sharma D.N., Sankaranarayanan R. Cancer of the cervix uteri. Intl. J. Gynecol. Obstet. 2018;143((Suppl. S2)):22–36. doi: 10.1002/ijgo.12611. - DOI - PubMed
    1. Cibula D., Pötter R., Planchamp F., Avall-Lundqvist E., Fischerova D., Meder C.H., Köhler C., Landoni F., Lax S., Lindegaard J.C., et al. The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients With Cervical Cancer. Int. J. Gynecol. Cancer. 2018;28:641–655. doi: 10.1097/IGC.0000000000001216. - DOI - PubMed
    1. Sturdza A., Pötter R., Fokdal L.U., Haie-Meder C., Tan L.T., Mazeron R., Petric P., Šegedin B., Jurgenliemk-Schulz I.M., Nomden C., et al. Image guided brachytherapy in locally advanced cervical cancer: Improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study. Radiother. Oncol. 2016;120:428–433. doi: 10.1016/j.radonc.2016.03.011. - DOI - PubMed
    1. Rema P., Mathew A.P., Suchetha S., Ahmed I. Salvage Surgery for Cervical Cancer Recurrences. Indian J. Surg. Oncol. 2015;8:146–149. doi: 10.1007/s13193-015-0472-2. - DOI - PMC - PubMed